Adel Iskander, MD
- 2Articles
- 4.7KReads
- 1998–2007Active
- 9Collaborators
About
Adel Iskander, MD, has contributed to research on schizophrenia and schizoaffective disorders, focusing on the treatment of primary negative symptoms and neurocognitive deficits. Publications include controlled trials comparing antipsychotic medications such as olanzapine, haloperidol, clozapine, and risperidone in patients with treatment-refractory schizophrenia. Iskander's work, published between 1998 and 2007, often involved collaboration with co-authors including Jean-Pierre Lindenmayer and Anzalee Khan.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
